Novostia SA

Novostia is a privately held medical device company developing an innovative artificial heart valve, particularly for young patients.
Novostia mission is to improve the quality of life of patients suffering from heart valve disease by providing them with a unique durable, low-thrombogenic, and silent heart valve prosthesis, overcoming the limitation of current technologies on the market.
Our technology results from years of R&D with world leaders in fluid mechanics, advanced biomaterials, high-precision Swiss manufacturing and prominent academic laboratories.
After extensive and outstanding in-vitro and in-vivo results, the company is now preparing first-in-human clinical trials, with the strong support from key opinion leaders.